Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal dexamethasone for bacterial endophthalmitis
NL-OMON28649Active, not recruiting
- Sponsor
- Het Oogziekenhuis Rotterdam
- Start
- Jan 2003
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of dexamethasone in endophthalmitis (2 arms), sponsored by Het Oogziekenhuis Rotterdam. Primary endpoints: Visual acuity by ETDRS at 3 months, Visual acuity by ETDRS at 6 months and 2 more. Started Jan 2003; status: active, not recruiting.
02
Drugs
dexamethasone
03
Conditions
endophthalmitis
Beyond the preview
Go deeper on NL-OMON28649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28649.